Pacific Biosciences of California, Inc. (PACB)

1.885 +0.06 (+3.57%) USD  |  NASDAQ  |  Dec 24, 12:59
1.885 0.00 (0.00%) After-Hours: 13:59
More

Pacific Biosciences of California CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Bruker Corp. Upgrade
ICU Medical, Inc. Upgrade
West Pharmaceutical Services, Inc. Upgrade
Clearpoint Neuro, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade